Mallikarjuna Sathish Kumar, Velayutham S Sakthi, Sowmini P R, Jeyaraj Malcolm K, Arunan S
Department of Neurology, Stanley Medical College, Chennai, Tamil Nadu, India.
J Neurosci Rural Pract. 2019 Jan-Mar;10(1):136-138. doi: 10.4103/jnrp.jnrp_150_18.
The unique association of myasthenia gravis (MG) with Graves' disease in clinical practice emphasizes that one autoimmune disease can coexist with another or many. The relationship between these two entities has remained controversial till date. Some authors have reported a see-saw relationship between these two entities, MG waning with hyperthyroidism and waxing with treatment of hyperthyroidism. Treatment of both these disorders concurrently may be challenging at times as treatment for one entity may worsen the other. The use of beta-blockers and steroids for Graves' disease may worsen myasthenic weakness. Antithyroid drugs can worsen myasthenia probably by immunomodulatory effects. We report a case of Graves' disease coexisting with MG in a reciprocal relationship which was subsequently reversed after immunotherapy.
重症肌无力(MG)与格雷夫斯病在临床实践中的独特关联强调了一种自身免疫性疾病可以与另一种或多种自身免疫性疾病共存。这两种疾病之间的关系至今仍存在争议。一些作者报道了这两种疾病之间的一种跷跷板关系,即MG在甲状腺功能亢进时减弱,在甲状腺功能亢进治疗时加重。同时治疗这两种疾病有时可能具有挑战性,因为针对一种疾病的治疗可能会使另一种疾病恶化。使用β受体阻滞剂和类固醇治疗格雷夫斯病可能会加重肌无力。抗甲状腺药物可能通过免疫调节作用加重重症肌无力。我们报告了一例格雷夫斯病与MG以相互关系共存的病例,该病例在免疫治疗后这种关系随后发生了逆转。